A Federal Judge has invalidated a major patent by Omni MedSci Inc.. Apple challenged this patent that was holding them back in introducing an Apple Watch feature that could track blood related metrics include glucose monitoring. All patent Claims of U.S. Patent 10,517,484 were considered "obvious," in light of previous patents. Apple petitioned the PTAB in January 2021 to cancel the entire '484 patent, arguing that the prior inventions rendered it obvious. Federal Circuit precedent required the ...